McKee Kelly T.'s most recent trade in Geovax Labs Inc was a trade of 1,107 Common Stock done at an average price of $0.7 . Disclosure was reported to the exchange on Aug. 7, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Geovax Labs Inc | Kelly T. McKee | Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 0.67 per share. | 07 Aug 2025 | 1,107 | 3,494 | - | 0.7 | 742 | Common Stock |
| Geovax Labs Inc | Kelly T. McKee | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2025 | 70,000 | 70,000 | - | - | Stock Option | |
| Geovax Labs Inc | Kelly T. McKee | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Aug 2024 | 15,700 | 15,700 | - | - | Stock Option | |
| Geovax Labs Inc | McKee Kelly T. | Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 0.36 per share. | 22 Dec 2023 | 6,944 | 35,782 | - | 0.4 | 2,500 | Common Stock |
| Geovax Labs Inc | Kelly T. McKee | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Aug 2023 | 15,000 | 15,000 | - | - | Stock Option | |
| Geovax Labs Inc | Kelly T. McKee | Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 1.12 per share. | 27 Jun 2022 | 4,464 | 19,185 | - | 1.1 | 5,000 | Common Stock |
| Geovax Labs Inc | Kelly T. McKee | Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 0.72 per share. | 05 May 2022 | 9,722 | 14,721 | - | 0.7 | 7,000 | Common Stock |
| Geovax Labs Inc | Kelly T. McKee | Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 0.71 per share. | 04 May 2022 | 4,999 | 4,999 | - | 0.7 | 3,549 | Common Stock |